IZM vs SONM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IZM presents a classic 'value trap' scenario; while the Piotroski F-Score of 6/9 indicates stable financial health and the stock trades significantly below its Graham Number ($1.7) and Intrinsic Value ($0.7), the price action is catastrophic. With a 75% decline over the last year and a technical trend score of 0/100, the market is pricing in a severe deterioration not yet fully reflected in the lagging P/E ratio. Razor-thin profit margins (0.64%) leave the company with virtually no margin for error in a volatile electronics distribution market.
The company exhibits extreme financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental health. With a Quick Ratio of 0.03 and a negative Price-to-Book ratio of -4.35, the firm is facing a severe liquidity crisis and possesses negative shareholders' equity. Catastrophic Q/Q revenue growth of -394.48% and a 5-year price decline of 99.7% suggest a business in terminal decline. The lack of an Altman Z-Score calculation is likely due to the absence of positive working capital or equity, further signaling insolvency risk.
Compare Another Pair
Related Comparisons
IZM vs SONM: Head-to-Head Comparison
This page compares ICZOOM Group Inc. (IZM) and DNA X, Inc. (SONM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.